Range Advisory, LLC’s AstraZeneca AZN Stock Holding History

Range Advisory, LLC’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$418K	Buy	2,207 +928	+73%	+$175K	0.05%	184
2026 Q1	$252K	Buy	+1,279	New	+$247K	0.05%	220

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Range Advisory, LLC's AZN Position: Q2 2026 in Review

Range Advisory, LLC increased its AstraZeneca (AZN) stake by 73% in Q2 2026, buying an estimated $175K and bringing the position to 2,207 shares worth $418K. The position accounts for 0.05% of the portfolio, ranked #184.

Range Advisory, LLC first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Range Advisory, LLC held 2,207 shares of AstraZeneca worth $418K as of Q2 2026.
Range Advisory, LLC bought 928 AstraZeneca shares in Q2 2026, an estimated $175K.
AstraZeneca made up 0.05% of Range Advisory, LLC's portfolio in Q2 2026, its #184 holding.
Range Advisory, LLC first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Range Advisory, LLC's 13F filing for Q2 2026, filed 2 Sep 2026.